Valter C Lima

Summary

Country: Brazil

Publications

  1. ncbi [Coronary angiography and angioplasty in diabetic patients]
    Valter C Lima
    Disciplina de Cardiologia, EPM, UNIFESP, and Serviço de Hemodinâmica e Cardiologia Intervencionista do Hospital São Paulo, SP, Brazil
    Arq Bras Endocrinol Metabol 51:299-304. 2007
  2. ncbi Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system
    Valter C Lima
    Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 87:e162-7. 2006
  3. doi Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial
    Pedro A Lemos
    Heart Institute InCor, University of São Paulo Medical School USP, Sao Paulo, Brazil
    EuroIntervention 8:117-9. 2012
  4. doi Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial
    Pedro A Lemos
    Catheterization Laboratory, Heart Institute InCor, University of São Paulo Medical School USP, Sao Paulo, Brazil
    Catheter Cardiovasc Interv 74:665-73. 2009
  5. ncbi Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion
    Rosley Weber Alvarenga Fernandes
    Hospital São Paulo SPDM Universidade Federal de São Paulo, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 98:290-8. 2012
  6. ncbi Clinical outcome of renal transplant patients after coronary stenting
    Fábio Monteiro Mota
    Hospital do Rim e Hipertensao, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 88:521-4. 2007
  7. ncbi Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients
    J Airton Arruda
    Hospital São Paulo and Hospital do Rim e Hipertensão, Federal University of Sao Paulo UNIFESP EPM, R Napoleão de Barros 715 Térreo, Sao Paulo, SP, Brazil 04024 002
    Am J Cardiol 91:1363-5. 2003
  8. ncbi [Prevalence of coronary artery disease in type I diabetic candidates for double transplantation (kidney and pancreas)]
    Dinaldo C Oliveira
    Hospital Sao Paulo, UNIFESP, Sao Paulo, SP
    Arq Bras Cardiol 84:108-10. 2005
  9. ncbi Orally administered rapamycin does not modify rat aortic vascular tone
    Milton de M Soares Neto
    Department of Cardiology, Federal University of Sao Paulo, Sao Paulo, Brazil
    J Cardiovasc Pharmacol 49:96-9. 2007
  10. ncbi Efficacy and safety of oral sirolimus to inhibit in-stent intimal hyperplasia
    Fabio S Brito
    Hospital São Paulo and Hospital do Rim e Hipertensão, Federal University of Sao Paulo, Brazil
    Catheter Cardiovasc Interv 64:413-8. 2005

Collaborators

  • Fabio S Brito
  • Pedro A Lemos
  • Marco A Costa
  • João Roberto de Sa
  • Rosley Weber Alvarenga Fernandes
  • Milton de M Soares Neto
  • Fábio Monteiro Mota
  • Dinaldo C Oliveira
  • Jose O M Pestana
  • J Airton Arruda
  • João Miguel Dantas
  • Hiram Grando Bezerra
  • Dinaldo Cavalcanti Oliveira
  • Juliana Araújo
  • Dulce E Casarini
  • Giovana S Di Marco
  • Alexandre H Campos
  • José Airton Arruda
  • Hélio T S Júnior
  • José Marconi A de Sousa
  • Alysson Nakamoto
  • Francival L Souza
  • Glauco Gusmão Filho
  • José O Medina Pestana
  • Adriano H P Barbosa
  • Erika P Ribeiro
  • Helio Tedesco

Detail Information

Publications11

  1. ncbi [Coronary angiography and angioplasty in diabetic patients]
    Valter C Lima
    Disciplina de Cardiologia, EPM, UNIFESP, and Serviço de Hemodinâmica e Cardiologia Intervencionista do Hospital São Paulo, SP, Brazil
    Arq Bras Endocrinol Metabol 51:299-304. 2007
    ..Conditions that favor surgery: long lesions, lesions in small vessels, presence of left anterior descending artery disease and need for associated valve surgery...
  2. ncbi Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system
    Valter C Lima
    Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 87:e162-7. 2006
    ....
  3. doi Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial
    Pedro A Lemos
    Heart Institute InCor, University of São Paulo Medical School USP, Sao Paulo, Brazil
    EuroIntervention 8:117-9. 2012
    ..The long-term clinical performance of drug-eluting stents (DES) coated with biodegradable polymers is poorly known...
  4. doi Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial
    Pedro A Lemos
    Catheterization Laboratory, Heart Institute InCor, University of São Paulo Medical School USP, Sao Paulo, Brazil
    Catheter Cardiovasc Interv 74:665-73. 2009
    ..The DES differed by the drug, but were identical otherwise, allowing to compare the anti-restenosis effects of sirolimus versus paclitaxel (secondary objective)...
  5. ncbi Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion
    Rosley Weber Alvarenga Fernandes
    Hospital São Paulo SPDM Universidade Federal de São Paulo, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 98:290-8. 2012
    ..There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal stenting (BMS)...
  6. ncbi Clinical outcome of renal transplant patients after coronary stenting
    Fábio Monteiro Mota
    Hospital do Rim e Hipertensao, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 88:521-4. 2007
    ..To assess the clinical outcome of renal transplant patients who developed coronary artery disease and were treated with coronary stenting (TCA-ST)...
  7. ncbi Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients
    J Airton Arruda
    Hospital São Paulo and Hospital do Rim e Hipertensão, Federal University of Sao Paulo UNIFESP EPM, R Napoleão de Barros 715 Térreo, Sao Paulo, SP, Brazil 04024 002
    Am J Cardiol 91:1363-5. 2003
  8. ncbi [Prevalence of coronary artery disease in type I diabetic candidates for double transplantation (kidney and pancreas)]
    Dinaldo C Oliveira
    Hospital Sao Paulo, UNIFESP, Sao Paulo, SP
    Arq Bras Cardiol 84:108-10. 2005
    ..To assess the prevalence of coronary artery disease (CAD) in a population of type I diabetic, nephropathic patients in a dialysis program and candidates for double transplantation (kidney and pancreas)...
  9. ncbi Orally administered rapamycin does not modify rat aortic vascular tone
    Milton de M Soares Neto
    Department of Cardiology, Federal University of Sao Paulo, Sao Paulo, Brazil
    J Cardiovasc Pharmacol 49:96-9. 2007
    ..Similar results were obtained after in vivo administration of the drug. These findings suggest that function of adult, non-proliferative rat endothelial cells involved in vascular tone control is not affected by orally administered RP...
  10. ncbi Efficacy and safety of oral sirolimus to inhibit in-stent intimal hyperplasia
    Fabio S Brito
    Hospital São Paulo and Hospital do Rim e Hipertensão, Federal University of Sao Paulo, Brazil
    Catheter Cardiovasc Interv 64:413-8. 2005
    ..2%) target vessel revascularizations. In conclusion, in this small group of high-risk ISR patients, oral sirolimus inhibited NIH and therefore may be an effective strategy for the prevention and treatment of ISR...
  11. ncbi [Tracking, diagnosis and revascularization of coronary arterial disease in type 2 diabetes: supreme challenges to contemporary medicine, also in Brazil!]
    Valter C Lima
    Arq Bras Endocrinol Metabol 50:1-3. 2006